The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $112.08

Today's change0.00 0.00%
Updated April 29 4:01 PM EDT. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $112.08

Today's change0.00 0.00%
Updated April 29 4:01 PM EDT. Delayed by at least 15 minutes.

Johnson & Johnson closed at (U.S.)$112.08.

Shares have lost 1.09% over the last five days, but sit 1.85% below their 52-week high. This security has outperformed the S&P 500 by 13.62% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $112.08
  • High--
  • Low--
  • Bid / Ask(U.S.) $110.52 / (U.S.) $114.02
  • YTD % change+9.11%
  • Volume0
  • Average volume (10-day)7,648,246
  • Average volume (1-month)7,621,129
  • Average volume (3-month)8,765,582
  • 52-week range(U.S.) $81.79 to (U.S.) $114.19
  • Beta0.58
  • Trailing P/E20.43×
  • P/E 1 year forward16.97×
  • Forward PEG3.00×
  • Indicated annual dividend(U.S.) $3.20
  • Dividend yield2.86%
  • Trailing EPS(U.S.) $5.49
Updated April 29 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 03, 201604/03/2016Jan 03, 201601/03/2016Sep 27, 201509/27/2015Jun 28, 201506/28/2015
Revenue17,48217,81117,10217,787
Total other revenue--------
Total revenue17,48217,81117,10217,787
Gross profit12,17012,13811,87812,430
Total cost of revenue5,3125,6735,2245,357
Total operating expense12,18814,05312,98012,046
Selling / general / administrative4,6885,8915,0815,384
Research & development2,0132,8642,1542,129
Depreciation / amortization--------
Interest expense (income), net operating--160123131
Unusual expense (income)137723100
Other operating expenses, total-39-1,205412-1,055
Operating income5,2943,7584,1225,741
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax5,2943,7584,1225,741
Income after tax4,2923,2153,3584,516
Income tax, total1,0025437641,225
Net income4,2923,2153,3584,516
Total adjustments to net income--------
Net income before extra. items4,2923,2153,3584,516
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4,2923,2153,3584,516
Inc. avail. to common incl. extra. items4,2923,2153,3584,516
Diluted net income4,2923,2153,3584,516
Dilution adjustment----00
Diluted weighted average shares2,7952,8002,8072,812
Diluted EPS excluding extraordinary itemsvalue per share1.541.151.201.61
Dividends per sharevalue per share--0.750.750.75
Diluted normalized EPSvalue per share1.561.571.201.61